New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy

William G Nelson, J. W. Simons

Research output: Contribution to journalArticle

Abstract

Some men affected with clinically localized prostate carcinoma suffer life-threatening recurrence, despite previous treatment with surgery or radiation therapy, underscoring the need for new, effective, systemic adjuvant treatment approaches. Recent molecular mechanism based prostate cancer drug discovery efforts have identified several candidate targets for systemic prostate cancer adjuvant therapy; however, traditional cancer treatment development algorithms may not be appropriate for many of the new treatment strategies. To best exploit the clinical potential of these molecular treatment strategies, novel translational research strategies are required to support hypothesis-driven clinical research and development.

Original languageEnglish (US)
Pages (from-to)685-696
Number of pages12
JournalUrologic Clinics of North America
Volume23
Issue number4
DOIs
StatePublished - 1996

Fingerprint

Prostatectomy
Prostatic Neoplasms
Therapeutics
Translational Medical Research
Drug Discovery
Prostate
Radiotherapy
Carcinoma
Recurrence
Research
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

@article{76b928787c3d4067be1a006f67cd6b5b,
title = "New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy",
abstract = "Some men affected with clinically localized prostate carcinoma suffer life-threatening recurrence, despite previous treatment with surgery or radiation therapy, underscoring the need for new, effective, systemic adjuvant treatment approaches. Recent molecular mechanism based prostate cancer drug discovery efforts have identified several candidate targets for systemic prostate cancer adjuvant therapy; however, traditional cancer treatment development algorithms may not be appropriate for many of the new treatment strategies. To best exploit the clinical potential of these molecular treatment strategies, novel translational research strategies are required to support hypothesis-driven clinical research and development.",
author = "Nelson, {William G} and Simons, {J. W.}",
year = "1996",
doi = "10.1016/S0094-0143(05)70346-3",
language = "English (US)",
volume = "23",
pages = "685--696",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy

AU - Nelson, William G

AU - Simons, J. W.

PY - 1996

Y1 - 1996

N2 - Some men affected with clinically localized prostate carcinoma suffer life-threatening recurrence, despite previous treatment with surgery or radiation therapy, underscoring the need for new, effective, systemic adjuvant treatment approaches. Recent molecular mechanism based prostate cancer drug discovery efforts have identified several candidate targets for systemic prostate cancer adjuvant therapy; however, traditional cancer treatment development algorithms may not be appropriate for many of the new treatment strategies. To best exploit the clinical potential of these molecular treatment strategies, novel translational research strategies are required to support hypothesis-driven clinical research and development.

AB - Some men affected with clinically localized prostate carcinoma suffer life-threatening recurrence, despite previous treatment with surgery or radiation therapy, underscoring the need for new, effective, systemic adjuvant treatment approaches. Recent molecular mechanism based prostate cancer drug discovery efforts have identified several candidate targets for systemic prostate cancer adjuvant therapy; however, traditional cancer treatment development algorithms may not be appropriate for many of the new treatment strategies. To best exploit the clinical potential of these molecular treatment strategies, novel translational research strategies are required to support hypothesis-driven clinical research and development.

UR - http://www.scopus.com/inward/record.url?scp=0030482690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030482690&partnerID=8YFLogxK

U2 - 10.1016/S0094-0143(05)70346-3

DO - 10.1016/S0094-0143(05)70346-3

M3 - Article

C2 - 8948421

AN - SCOPUS:0030482690

VL - 23

SP - 685

EP - 696

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 4

ER -